CYTOMX THERAPEUTICS

cytomx-therapeutics-logo

CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

CYTOMX THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2008-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.cytomx.com

Total Employee:
51+

Status:
Active

Contact:
6503510353

Total Funding:
345.42 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Nginx Amazon IPv6 AJAX Libraries API


Similar Organizations

aquabounty-technologies-logo

AquaBounty Technologies

AquaBounty Technologies is a biotechnology company that focuses on improving productivity in commercial aquaculture.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.


Current Advisors List

hoyoung-huh_image

Hoyoung Huh Chairman @ CytomX Therapeutics
Board_member

charles-homcy_image

Charles Homcy Member of the Board of Directors @ CytomX Therapeutics
Board_member

neil-exter_image

Neil Exter Board of Directors @ CytomX Therapeutics
Board_member

john-maraganore_image

John Maraganore Member of the Board of Directors @ CytomX Therapeutics
Board_member

fred-gluck_image

Fred Gluck Board of Directors @ CytomX Therapeutics
Board_member

timothy-shannon_image

Timothy Shannon Board Member @ CytomX Therapeutics
Board_member

halley-gilbert_image

HALLEY GILBERT Board Member @ CytomX Therapeutics
Board_member
2020-04-01

Current Employees Featured

sean-mccarthy_image

Sean McCarthy
Sean McCarthy Chief Executive Officer @ CytomX Therapeutics
Chief Executive Officer
2011-08-01

carol-talkington-verser_image

Carol Talkington Verser
Carol Talkington Verser Sr. Director & Head, Intellectual Property @ CytomX Therapeutics
Sr. Director & Head, Intellectual Property
2013-01-01

james-w-west_image

James W. West
James W. West Research Fellow @ CytomX Therapeutics
Research Fellow

amy-peterson_image

Amy Peterson
Amy Peterson President & Chief Operating Officer @ CytomX Therapeutics
President & Chief Operating Officer
2022-02-01

michael-kavanaugh_image

Michael Kavanaugh
Michael Kavanaugh Member, Scientific Advisory Board @ CytomX Therapeutics
Member, Scientific Advisory Board
2020-12-01

james-w-west_image

James W. West
James W. West Director of Research @ CytomX Therapeutics
Director of Research
2008-07-01

Founder


fred-gluck_image

Fred Gluck

patrick-daugherty_image

Patrick Daugherty

Stock Details


Company's stock symbol is NASDAQ:CTMX

Acquisitions List

Date Company Article Price
2005-03-30 Ardais Corporation Ardais Corporation acquired by CytomX Therapeutics N/A

Investors List

wellington-management_image

Wellington Management

Wellington Management investment in Series D - CytomX Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series D - CytomX Therapeutics

deerfield_image

Deerfield

Deerfield investment in Series D - CytomX Therapeutics

casdin-capital_image

Casdin Capital

Casdin Capital investment in Series D - CytomX Therapeutics

tekla-capital-management_image

Tekla Capital Management

Tekla Capital Management investment in Series D - CytomX Therapeutics

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series D - CytomX Therapeutics

venrock_image

Venrock

Venrock investment in Series D - CytomX Therapeutics

redmile-group_image

Redmile Group

Redmile Group investment in Series D - CytomX Therapeutics

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series C - CytomX Therapeutics

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series C - CytomX Therapeutics

Official Site Inspections

http://www.cytomx.com Semrush global rank: 40.86 K Semrush visits lastest month: 3.13 M

  • Host name: 73.38.148.146.bc.googleusercontent.com
  • IP address: 146.148.38.73
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "CytomX Therapeutics" on Search Engine